These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 31752131)
1. The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome. AbdelMageed M; Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752131 [TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients. AbdelMageed M; Ismail HTH; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008827 [TBL] [Abstract][Full Text] [Related]
4. Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer. Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B Tumour Biol; 2020 Jun; 42(6):1010428320924524. PubMed ID: 32515296 [TBL] [Abstract][Full Text] [Related]
5. Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer. Ali H; AbdelMageed M; Olsson L; Israelsson A; Lindmark G; Hammarström ML; Hammarström S; Sitohy B Tumour Biol; 2019 Jun; 41(6):1010428319858885. PubMed ID: 31250711 [TBL] [Abstract][Full Text] [Related]
6. The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer. Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B Tumour Biol; 2021; 43(1):209-223. PubMed ID: 34486997 [TBL] [Abstract][Full Text] [Related]
7. Ectopic expression of the chemokine CXCL17 in colon cancer cells. Ohlsson L; Hammarström ML; Lindmark G; Hammarström S; Sitohy B Br J Cancer; 2016 Mar; 114(6):697-703. PubMed ID: 26889977 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Ismail HTH; AbdelMageed M; Lindmark G; Hammarström ML; Hammarström S; Sitohy B Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562947 [TBL] [Abstract][Full Text] [Related]
9. Expression and effect of CXCL14 in colorectal carcinoma. Lin K; Zou R; Lin F; Zheng S; Shen X; Xue X Mol Med Rep; 2014 Sep; 10(3):1561-8. PubMed ID: 24938992 [TBL] [Abstract][Full Text] [Related]
10. The potential of cytokeratin 20 and mucin 2 mRNA as metastasis markers in regional lymph nodes of colon cancer patients investigated by quantitative RT-PCR. Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R Int J Colorectal Dis; 2009 Mar; 24(3):261-8. PubMed ID: 19119477 [TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. Hald SM; Kiselev Y; Al-Saad S; Richardsen E; Johannessen C; Eilertsen M; Kilvaer TK; Al-Shibli K; Andersen S; Busund LT; Bremnes RM; Donnem T BMC Cancer; 2015 May; 15():441. PubMed ID: 26021984 [TBL] [Abstract][Full Text] [Related]
12. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer. Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic values of C‑X‑C motif chemokine ligand 3 in patients with colon cancer. Ruan GT; Gong YZ; Liao XW; Wang S; Huang W; Wang XK; Zhu GZ; Liao C; Gao F Oncol Rep; 2019 Nov; 42(5):1996-2008. PubMed ID: 31545503 [TBL] [Abstract][Full Text] [Related]
14. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. Gutwein P; Schramme A; Sinke N; Abdel-Bakky MS; Voss B; Obermüller N; Doberstein K; Koziolek M; Fritzsche F; Johannsen M; Jung K; Schaider H; Altevogt P; Ludwig A; Pfeilschifter J; Kristiansen G Eur J Cancer; 2009 Feb; 45(3):478-89. PubMed ID: 19070478 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation. Matsumura S; Demaria S Radiat Res; 2010 Apr; 173(4):418-25. PubMed ID: 20334513 [TBL] [Abstract][Full Text] [Related]
16. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer. Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368 [TBL] [Abstract][Full Text] [Related]
17. Expression of CXCL14 and its anticancer role in breast cancer. Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931 [TBL] [Abstract][Full Text] [Related]
18. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation. Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516 [TBL] [Abstract][Full Text] [Related]
19. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer. Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival. Doll D; Keller L; Maak M; Boulesteix AL; Siewert JR; Holzmann B; Janssen KP Int J Colorectal Dis; 2010 May; 25(5):573-81. PubMed ID: 20162422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]